Study to Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants

NCT00366548 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

500

Enrollment

INDUSTRY

Sponsor class

Conditions

Vaccines, Pneumococcal

Interventions

BIOLOGICAL: 13 valent pneumococcal conjugate vaccine with Polysorbate 80
BIOLOGICAL: 13 valent pneumococcal conjugate vaccine without Polysorbate 80

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer